Cargando…
The significance of highlighting the oestrogen receptor low category in breast cancer
The latest ASCO/CAP guideline has recommended to report oestrogen receptor (ER) low cases (ER(lo); 1–10%) as “ER low positive category”, prompting us to compare the clinicopathologic features, biomarkers, survival and treatment of the ER(lo) cases with other subgroups (ER negative (ER(neg)) and ER h...
Autores principales: | Poon, Ivan K., Tsang, Julia Y., Li, Joshua, Chan, Siu-Ki, Shea, Ka-Ho, Tse, Gary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555863/ https://www.ncbi.nlm.nih.gov/pubmed/32713939 http://dx.doi.org/10.1038/s41416-020-1009-1 |
Ejemplares similares
-
Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes
por: Ni, Yunbi, et al.
Publicado: (2022) -
Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016) -
Of Oestrogens and Sperm: A Review of the Roles of Oestrogens and Oestrogen Receptors in Male Reproduction
por: Dostalova, Pavla, et al.
Publicado: (2017) -
A-FABP and oestrogens are independently involved in the development of breast cancer
por: Li, Bing, et al.
Publicado: (2019) -
Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)